- Delivering Pan India
Onglyza® (Saxagliptin) Saxagliptin 2.5 mg and Saxagliptin 5 mg tablets by AstraZeneca. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Saxagliptin 2.5 mg / Saxagliptin 5 mg |
|---|---|
| Manufacturer | AstraZeneca |
| Country | India |
| Pack size | Saxagliptin 2.5 mg: 2 x 14 tablets (as shown on the carton); Saxagliptin 5 mg: 2 x 14 tablets (as shown on the carton) |
| Storage | Store as per the carton; the US reference label describes 20°C to 25°C. |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Onglyza® (Saxagliptin) Saxagliptin 2.5 mg and Saxagliptin 5 mg Tablets — DPP-4 Inhibitor Tablets: A Sourcing Guide for Hospitals and Pharmacies
Onglyza® is a brand of saxagliptin film-coated tablets (2.5 mg and 5 mg) from AstraZeneca, shown on the cartons as packs of 2 x 14 tablets. According to the current US prescribing information, saxagliptin is a dipeptidyl peptidase-4 (DPP4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Indications in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe saxagliptin, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Onglyza® (saxagliptin) Saxagliptin 2.5 mg and Saxagliptin 5 mg tablets to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the diabetes medicines category. Supply is in bulk/wholesale quantities only.
Onglyza contains saxagliptin (as saxagliptin hydrochloride) in 2.5 mg and 5 mg film-coated tablets, supplied in the pack sizes listed below.
How it works, according to the label: The reference label describes saxagliptin as a DPP4 inhibitor, which slows the inactivation of incretin hormones and so increases their levels.
The current US prescribing information for ONGLYZA® (saxagliptin) tablets (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Onglyza pack insert.
The reference label summarises its Clinical Studies in type 2 diabetes. The SAVOR-TIMI 53 cardiovascular outcomes study of saxagliptin was published by Scirica et al. in the New England Journal of Medicine in 2013. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Saxagliptin 2.5 mg | Film-coated tablets | 2 x 14 tablets (as shown on the carton) |
| Saxagliptin 5 mg | Film-coated tablets | 2 x 14 tablets (as shown on the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, endocrinology and diabetology department buyers and pharmacies that source antidiabetic products. The product is prescribed and supervised by a physician, as described in the prescribing information.
The reference label lists upper respiratory tract infection, urinary tract infection and headache as adverse reactions reported in 5% or more of patients and more often than with placebo. Warnings include heart failure, pancreatitis, hypersensitivity and hypoglycaemia. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Onglyza carton and strip. For reference, the US label describes storage at 20°C to 25°C. Keep out of reach of children.
Onglyza is marketed by AstraZeneca. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Onglyza through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Onglyza available in India?
A.K. Pharma supplies Onglyza (saxagliptin) Saxagliptin 2.5 mg and Saxagliptin 5 mg tablets to hospitals and pharmacies in India. Contact us for current availability.
What does Onglyza contain?
Saxagliptin, a DPP-4 inhibitor, in 2.5 mg and 5 mg film-coated tablets.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Onglyza be stored?
Follow the carton and strip; the US reference label describes 20°C to 25°C.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
